B. Jana

发表

Fate of CMY-2-Encoding Plasmids Introduced into the Human Fecal Microbiota by Exogenous Escherichia coli

S. Sørensen, D. Nielsen, V. Bortolaia, 2019, Antimicrobial Agents and Chemotherapy.

A culture-independent method for studying transfer of IncI1 plasmids from wild-type Escherichia coli in complex microbial communities.

S. Sørensen, D. Nielsen, V. Bortolaia, 2018, Journal of microbiological methods.

In vitro interaction between calf thymus DNA and Escherichia coli LPS in the presence of divalent cation Ca2+.

B. Jana, T. Basu, Pulakesh Aich, 2008, Biopolymers.

Repurposing azithromycin and rifampicin against Gram-negative pathogens by combination with peptide potentiators.

H. M. Nielsen, B. Jana, L. Guardabassi, 2019, International journal of antimicrobial agents.

Repurposing Azithromycin and Rifampicin Against Gram-Negative Pathogens by Combination With Peptidomimetics

H. M. Nielsen, B. Jana, L. Guardabassi, 2019, Front. Cell. Infect. Microbiol..

New route to the synthesis of bis[N-(2-aminoethyl) salicylaldiminato] chromium(III) chloride monohydrate Spectroscopic characterization, crystal structure and interaction with DNA.

B. Jana, G. Yap, K. Dey, 2006, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

Structure–Activity Study, Characterization, and Mechanism of Action of an Antimicrobial Peptoid D2 and Its d- and l-Peptide Analogues

Ines Greco, B. Jana, L. Guardabassi, 2019, Molecules.

Transcriptome analysis of extended-spectrum β-lactamase-producing Escherichia coli and methicillin-resistant Staphylococcus aureus exposed to cefotaxime

B. Jana, L. Guardabassi, A. Hesketh, 2018, Scientific Reports.

Antimicrobial synergy between carprofen and doxycycline against methicillin-resistant Staphylococcus pseudintermedius ST71

B. Jana, L. Guardabassi, Zofia Magnowska, 2016, BMC Veterinary Research.

Studies on the Escherichia coli ExbD Transmembrane Domain, Residue L132, and an Inhibitory Cyclic Peptide

K. Postle, B. Jana, Dale R. Kopp, 2022, bioRxiv.

Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections

Ines Greco, B. Jana, L. Guardabassi, 2019, Scientific Reports.

Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double‐blind, placebo‐controlled Phase 2 trial

H. M. Nielsen, T. Rades, N. Sørensen, 2022, Clinical and translational medicine.

ExbB Cytoplasmic Loop Deletions Cause Immediate, Proton Motive Force-Independent Growth Arrest

K. Postle, B. Jana, K. Baker, 2013, Journal of bacteriology.

Mutations in the ExbB Cytoplasmic Carboxy Terminus Prevent Energy-Dependent Interaction between the TonB and ExbD Periplasmic Domains

K. Postle, B. Jana, M. Manning, 2011, Journal of bacteriology.

The secondary resistome of multidrug-resistant Klebsiella pneumoniae

Amy K. Cain, Christine J. Boinett, J. Parkhill, 2017, Scientific Reports.

Insight Into the Anti-staphylococcal Activity of JBC 1847 at Sub-Inhibitory Concentration

A. Friedrich, M. Monaco, K. Holmstrøm, 2022, Frontiers in Microbiology.

A genome-wide atlas of antibiotic susceptibility targets and pathways to tolerance

C. Rock, J. Rosch, B. Jana, 2022, Nature Communications.

Carprofen-induced depletion of proton motive force reverses TetK-mediated doxycycline resistance in methicillin-resistant Staphylococcus pseudintermedius

R. Lametsch, B. Jana, L. Guardabassi, 2019, Scientific Reports.

Cephem Potentiation by Inactivation of Nonessential Genes Involved in Cell Wall Biogenesis of β-Lactamase-Producing Escherichia coli

B. Jana, L. Guardabassi, K. Baker, 2016, Antimicrobial Agents and Chemotherapy.

A High-Throughput Approach To Identify Compounds That Impair Envelope Integrity in Escherichia coli

B. Jana, L. Guardabassi, H. Franzyk, 2016, Antimicrobial Agents and Chemotherapy.

Role of membrane potential on artificial transformation of E. coli with plasmid DNA.

S. Saha, B. Jana, T. Basu, 2006, Journal of biotechnology.

How does plasmid DNA penetrate cell membranes in artificial transformation process of Escherichia coli?

B. Jana, T. Basu, Pulakesh Aich, 2008, Molecular membrane biology.

DNA Damage Repair and Drug Efflux as Potential Targets for Reversing Low or Intermediate Ciprofloxacin Resistance in E. coli K-12

B. Jana, L. Guardabassi, K. Nielsen, 2018, Front. Microbiol..

Damage Repair and Drug Efflux as Potential Targets for Reversing Low or Intermediate Ciprofloxacin Resistance in E . coli K-12 Klitgaard

B. Jana, L. Guardabassi, K. Nielsen, 2018 .

CRISPRi-TnSeq: A genome-wide high-throughput tool for bacterial essential-nonessential genetic interaction mapping

J. Veening, B. Jana, T. van Opijnen, 2023, bioRxiv.

Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections

Ines Greco, B. Jana, L. Guardabassi, 2019, Scientific Reports.

Accumulation of the periplasmic protein alkaline phosphatase in cell cytosol induces heat shock response in E. coli

B. Jana, T. Basu, S. Chaudhuri, 2004 .

Studies on the Escherichia coli ExbD Transmembrane Domain, Residue L132, and an Inhibitory Cyclic Peptide

K. Postle, B. Jana, Dale R. Kopp, 2023, bioRxiv.

In Silico Prediction and Prioritization of Novel Selective Antimicrobial Drug Targets in Escherichia coli

B. Jana, L. Guardabassi, S. Donadio, 2021, Antibiotics.

In Silico Prediction and Prioritisation of Novel Selective Antimicrobial Drug Targets in Escherichia Coli

B. Jana, L. Guardabassi, S. Donadio, 2021 .

Transcriptome analysis of extended-spectrum β-lactamase-producing Escherichia coli and methicillin-resistant Staphylococcus aureus exposed to cefotaxime

B. Jana, L. Guardabassi, A. Hesketh, 2018, Scientific Reports.

Breaking Gram-negative envelope barriers : a high-throughput approach to identify compounds 1 that impair envelope integrity in Escherichia coli 2 3

B. Jana, L. Guardabassi, H. Franzyk, 2016 .

Dogs as reservoirs of Escherichia coli strains causing urinary tract infection in their owners

H. Gumpert, B. Jana, L. Guardabassi, 2018, bioRxiv.